Impaired platelet mitochondrial activity in Alzheimer's disease and mild cognitive impairment

被引:143
作者
Valla, Jon
Schneider, Lonnie
Niedzielko, Tracy
Coon, Keith D.
Caselli, Richard
Sabbaah, Marwan N.
Ahern, Geoffrey L.
Baxter, Leslie
Alexander, Gene
Walker, Douglas G.
Reiman, Eric M.
机构
[1] St Josephs Hosp, Barrow Neurol Inst, Arizona Alzheimers Dis Consortium, Phoenix, AZ 85013 USA
[2] Translat Genom Res Inst, Phoenix, AZ USA
[3] Mayo Clin Arizona, Dept Neurol, Scottsdale, AZ USA
[4] Arizona Alzheimers Dis Consortium, Scottsdale, AZ USA
[5] Arizona Alzheimers Dis Consortium, Sun City, AZ USA
[6] Cleo Roberts Ctr Clin Res, Sun Hlth Res Inst, Sun City, AZ USA
[7] Arizona Alzheimers Dis Consortium, Tucson, AZ USA
[8] Univ Arizona, Hlth Sci Ctr, Tucson, AZ USA
[9] Arizona Alzheimers Dis Consortium, Tempe, AZ USA
[10] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA
[11] Univ Arizona, Banner Alzheimers Inst, Translat Genom Res Inst, Phoenix, AZ USA
关键词
cytochrome oxidase; cytochrome reductase; electron transport chain; Alzheimer's disease; mild cognitive impairment; at-risk population;
D O I
10.1016/j.mito.2006.10.004
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mitochondrial abnormalities are found in Alzheimer's disease (AD), but previous reports have not examined at-risk groups. In subjects with AD, mild cognitive impairment (MCI), and non-demented aged controls, platelet and lymphocyte mitochondria were isolated and analyzed for Complexes I, III and IV of the electron transport chain. Western blots Were used to control for differential enrichment of samples. Results demonstrated significant declines in Complexes III and IV in AD, and a significant decline in Complex IV in MCI. This report confirms mitochondrial deficiencies in AD, extends them to MCI, and suggests they are present at the earliest symptomatic stages of disease. (c) 2006 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
引用
收藏
页码:323 / 330
页数:8
相关论文
共 53 条
[1]   β-amyloid neurotoxicity is exacerbated during glycolysis inhibition and mitochondrial impairment in the rat hippocampus in vivo and in isolated nerve terminals:: Implications for Alzheimer's disease [J].
Arias, C ;
Montiel, T ;
Quiroz-Báez, R ;
Massieu, L .
EXPERIMENTAL NEUROLOGY, 2002, 176 (01) :163-174
[2]   In vivo and in organello assessment of OXPHOS activities [J].
Barrientos, A .
METHODS, 2002, 26 (04) :307-316
[3]   Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease [J].
Bosetti, F ;
Brizzi, F ;
Barogi, S ;
Mancuso, M ;
Siciliano, G ;
Tendi, EA ;
Murri, L ;
Rapoport, SI ;
Solaini, G .
NEUROBIOLOGY OF AGING, 2002, 23 (03) :371-376
[4]   Mitochondria dysfunction of Alzheimer's disease cybrids enhances Aβ toxicity [J].
Cardoso, SM ;
Santana, I ;
Swerdlow, RH ;
Oliveira, CR .
JOURNAL OF NEUROCHEMISTRY, 2004, 89 (06) :1417-1426
[5]   Cytochrome c oxidase is decreased in Alzheimer's disease platelets [J].
Cardoso, SM ;
Proença, MT ;
Santos, S ;
Santana, I ;
Oliveira, CR .
NEUROBIOLOGY OF AGING, 2004, 25 (01) :105-110
[6]   Mitochondrial Aβ:: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease [J].
Caspersen, C ;
Wang, N ;
Yao, J ;
Sosunov, A ;
Chen, X ;
Lustbader, JW ;
Xu, HW ;
Stern, D ;
McKhann, G ;
Yan, SD .
FASEB JOURNAL, 2005, 19 (12) :2040-+
[7]   Cyclosporin A increases resting mitochondrial membrane potential in SY5Y cells and reverses the depressed mitochondrial membrane potential of Alzheimer's disease cybrids [J].
Cassarino, DS ;
Swerdlow, RH ;
Parks, JK ;
Parker, WD ;
Bennett, JP .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (01) :168-173
[8]   DISTRIBUTION OF BRAIN CYTOCHROME-OXIDASE ACTIVITY IN VARIOUS NEURODEGENERATIVE DISEASES [J].
CHAGNON, P ;
BETARD, C ;
ROBITAILLE, Y ;
CHOLETTE, A ;
GAUVREAU, D .
NEUROREPORT, 1995, 6 (05) :711-715
[9]   Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing [J].
Coon, Keith D. ;
Valla, Jon ;
Szelinger, Szabolics ;
Schneider, Lonnie E. ;
Niedzielko, Tracy L. ;
Brown, Kevin M. ;
Pearson, John V. ;
Halperin, Rebecca ;
Dunckley, Travis ;
Papassotiropoulos, Andreas ;
Caselli, Richard J. ;
Reiman, Eric M. ;
Stephan, Dietrich A. .
MITOCHONDRION, 2006, 6 (04) :194-210
[10]   Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42 [J].
Crouch, PJ ;
Blake, R ;
Duce, JA ;
Ciccotosto, GD ;
Li, QX ;
Barnham, KJ ;
Curtain, CC ;
Cherny, RA ;
Cappai, R ;
Dyrks, T ;
Masters, CL ;
Trounce, IA .
JOURNAL OF NEUROSCIENCE, 2005, 25 (03) :672-679